Research Paper Volume 14, Issue 19 pp 7866—7876
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
Figure 4. ROC and Kaplan-Meier curves of DTYMK. (A–C) Kaplan–Meier survival curves showed that lung adenocarcinoma patients with high DTYMK expression exhibited poor overall survival, disease-specific survival and progression-free survival of DTYMK in LUAD determine by TCGA-LUAD dataset. (D) ROC curves were used to determine the diagnostic value of DTYMK in lung adenocarcinoma. (E, F) Kaplan–Meier survival curves showed that lung adenocarcinoma patients with high DTYMK expression exhibited poor overall survival determine by GEO dataset.